Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 12 |
NetGPI | no | yes: 0, no: 12 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 13 |
GO:0110165 | cellular anatomical entity | 1 | 13 |
Related structures:
AlphaFold database: A0A3S5H6A1
Term | Name | Level | Count |
---|---|---|---|
GO:0006355 | regulation of DNA-templated transcription | 6 | 1 |
GO:0006357 | regulation of transcription by RNA polymerase II | 7 | 1 |
GO:0009889 | regulation of biosynthetic process | 4 | 1 |
GO:0009891 | positive regulation of biosynthetic process | 5 | 1 |
GO:0009893 | positive regulation of metabolic process | 4 | 1 |
GO:0010468 | regulation of gene expression | 5 | 1 |
GO:0010556 | regulation of macromolecule biosynthetic process | 5 | 1 |
GO:0010557 | positive regulation of macromolecule biosynthetic process | 6 | 1 |
GO:0010604 | positive regulation of macromolecule metabolic process | 5 | 1 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 5 | 1 |
GO:0019222 | regulation of metabolic process | 3 | 1 |
GO:0031323 | regulation of cellular metabolic process | 4 | 1 |
GO:0031325 | positive regulation of cellular metabolic process | 5 | 1 |
GO:0031326 | regulation of cellular biosynthetic process | 5 | 1 |
GO:0031328 | positive regulation of cellular biosynthetic process | 6 | 1 |
GO:0045893 | positive regulation of DNA-templated transcription | 7 | 1 |
GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 6 | 1 |
GO:0045944 | positive regulation of transcription by RNA polymerase II | 8 | 1 |
GO:0048518 | positive regulation of biological process | 3 | 1 |
GO:0048522 | positive regulation of cellular process | 4 | 1 |
GO:0050789 | regulation of biological process | 2 | 1 |
GO:0050794 | regulation of cellular process | 3 | 1 |
GO:0051171 | regulation of nitrogen compound metabolic process | 4 | 1 |
GO:0051173 | positive regulation of nitrogen compound metabolic process | 5 | 1 |
GO:0051252 | regulation of RNA metabolic process | 5 | 1 |
GO:0051254 | positive regulation of RNA metabolic process | 6 | 1 |
GO:0060255 | regulation of macromolecule metabolic process | 4 | 1 |
GO:0065007 | biological regulation | 1 | 1 |
GO:0080090 | regulation of primary metabolic process | 4 | 1 |
GO:1902680 | positive regulation of RNA biosynthetic process | 7 | 1 |
GO:1903506 | regulation of nucleic acid-templated transcription | 7 | 1 |
GO:1903508 | positive regulation of nucleic acid-templated transcription | 8 | 1 |
GO:2001141 | regulation of RNA biosynthetic process | 6 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005488 | binding | 1 | 13 |
GO:0043167 | ion binding | 2 | 13 |
GO:0043169 | cation binding | 3 | 13 |
GO:0046872 | metal ion binding | 4 | 13 |
GO:0000976 | transcription cis-regulatory region binding | 5 | 1 |
GO:0001067 | transcription regulatory region nucleic acid binding | 4 | 1 |
GO:0003676 | nucleic acid binding | 3 | 1 |
GO:0003677 | DNA binding | 4 | 1 |
GO:0003690 | double-stranded DNA binding | 5 | 1 |
GO:0043565 | sequence-specific DNA binding | 5 | 1 |
GO:0097159 | organic cyclic compound binding | 2 | 1 |
GO:1901363 | heterocyclic compound binding | 2 | 1 |
GO:1990837 | sequence-specific double-stranded DNA binding | 6 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 280 | 284 | PF00656 | 0.552 |
CLV_NRD_NRD_1 | 163 | 165 | PF00675 | 0.377 |
CLV_NRD_NRD_1 | 189 | 191 | PF00675 | 0.483 |
CLV_NRD_NRD_1 | 210 | 212 | PF00675 | 0.408 |
CLV_NRD_NRD_1 | 383 | 385 | PF00675 | 0.422 |
CLV_NRD_NRD_1 | 431 | 433 | PF00675 | 0.530 |
CLV_NRD_NRD_1 | 50 | 52 | PF00675 | 0.522 |
CLV_NRD_NRD_1 | 556 | 558 | PF00675 | 0.659 |
CLV_NRD_NRD_1 | 64 | 66 | PF00675 | 0.379 |
CLV_NRD_NRD_1 | 94 | 96 | PF00675 | 0.451 |
CLV_PCSK_KEX2_1 | 189 | 191 | PF00082 | 0.431 |
CLV_PCSK_KEX2_1 | 201 | 203 | PF00082 | 0.339 |
CLV_PCSK_KEX2_1 | 210 | 212 | PF00082 | 0.385 |
CLV_PCSK_KEX2_1 | 383 | 385 | PF00082 | 0.532 |
CLV_PCSK_KEX2_1 | 431 | 433 | PF00082 | 0.534 |
CLV_PCSK_KEX2_1 | 50 | 52 | PF00082 | 0.528 |
CLV_PCSK_KEX2_1 | 508 | 510 | PF00082 | 0.585 |
CLV_PCSK_KEX2_1 | 64 | 66 | PF00082 | 0.369 |
CLV_PCSK_KEX2_1 | 94 | 96 | PF00082 | 0.487 |
CLV_PCSK_PC1ET2_1 | 201 | 203 | PF00082 | 0.397 |
CLV_PCSK_PC1ET2_1 | 508 | 510 | PF00082 | 0.555 |
CLV_PCSK_SKI1_1 | 12 | 16 | PF00082 | 0.412 |
CLV_PCSK_SKI1_1 | 288 | 292 | PF00082 | 0.396 |
CLV_PCSK_SKI1_1 | 318 | 322 | PF00082 | 0.625 |
CLV_PCSK_SKI1_1 | 349 | 353 | PF00082 | 0.471 |
CLV_PCSK_SKI1_1 | 414 | 418 | PF00082 | 0.492 |
CLV_PCSK_SKI1_1 | 558 | 562 | PF00082 | 0.598 |
CLV_PCSK_SKI1_1 | 64 | 68 | PF00082 | 0.390 |
DEG_APCC_DBOX_1 | 287 | 295 | PF00400 | 0.509 |
DEG_APCC_DBOX_1 | 76 | 84 | PF00400 | 0.525 |
DEG_SCF_FBW7_2 | 247 | 254 | PF00400 | 0.413 |
DEG_SCF_FBW7_2 | 319 | 326 | PF00400 | 0.696 |
DEG_SPOP_SBC_1 | 532 | 536 | PF00917 | 0.706 |
DOC_CKS1_1 | 172 | 177 | PF01111 | 0.441 |
DOC_CKS1_1 | 248 | 253 | PF01111 | 0.421 |
DOC_CKS1_1 | 320 | 325 | PF01111 | 0.699 |
DOC_CYCLIN_RxL_1 | 285 | 292 | PF00134 | 0.486 |
DOC_CYCLIN_yCln2_LP_2 | 172 | 178 | PF00134 | 0.395 |
DOC_MAPK_gen_1 | 383 | 394 | PF00069 | 0.371 |
DOC_MAPK_gen_1 | 94 | 102 | PF00069 | 0.542 |
DOC_PP2B_LxvP_1 | 217 | 220 | PF13499 | 0.585 |
DOC_PP2B_LxvP_1 | 408 | 411 | PF13499 | 0.479 |
DOC_PP2B_LxvP_1 | 481 | 484 | PF13499 | 0.630 |
DOC_PP4_FxxP_1 | 124 | 127 | PF00568 | 0.305 |
DOC_USP7_MATH_1 | 532 | 536 | PF00917 | 0.651 |
DOC_USP7_MATH_1 | 544 | 548 | PF00917 | 0.432 |
DOC_USP7_MATH_1 | 560 | 564 | PF00917 | 0.552 |
DOC_USP7_UBL2_3 | 352 | 356 | PF12436 | 0.476 |
DOC_USP7_UBL2_3 | 550 | 554 | PF12436 | 0.606 |
DOC_USP7_UBL2_3 | 558 | 562 | PF12436 | 0.717 |
DOC_WW_Pin1_4 | 117 | 122 | PF00397 | 0.456 |
DOC_WW_Pin1_4 | 171 | 176 | PF00397 | 0.537 |
DOC_WW_Pin1_4 | 247 | 252 | PF00397 | 0.420 |
DOC_WW_Pin1_4 | 309 | 314 | PF00397 | 0.563 |
DOC_WW_Pin1_4 | 319 | 324 | PF00397 | 0.631 |
DOC_WW_Pin1_4 | 460 | 465 | PF00397 | 0.529 |
DOC_WW_Pin1_4 | 568 | 573 | PF00397 | 0.731 |
LIG_14-3-3_CanoR_1 | 137 | 145 | PF00244 | 0.344 |
LIG_14-3-3_CanoR_1 | 210 | 217 | PF00244 | 0.517 |
LIG_14-3-3_CanoR_1 | 245 | 251 | PF00244 | 0.469 |
LIG_14-3-3_CanoR_1 | 318 | 323 | PF00244 | 0.730 |
LIG_14-3-3_CanoR_1 | 437 | 445 | PF00244 | 0.486 |
LIG_Actin_WH2_2 | 343 | 360 | PF00022 | 0.487 |
LIG_AP2alpha_2 | 214 | 216 | PF02296 | 0.534 |
LIG_APCC_ABBA_1 | 330 | 335 | PF00400 | 0.491 |
LIG_FHA_1 | 274 | 280 | PF00498 | 0.588 |
LIG_FHA_1 | 365 | 371 | PF00498 | 0.427 |
LIG_FHA_1 | 380 | 386 | PF00498 | 0.370 |
LIG_FHA_1 | 473 | 479 | PF00498 | 0.669 |
LIG_FHA_1 | 84 | 90 | PF00498 | 0.476 |
LIG_FHA_2 | 118 | 124 | PF00498 | 0.424 |
LIG_FHA_2 | 319 | 325 | PF00498 | 0.607 |
LIG_Integrin_RGD_1 | 526 | 528 | PF01839 | 0.646 |
LIG_LIR_Apic_2 | 122 | 127 | PF02991 | 0.338 |
LIG_LIR_Apic_2 | 48 | 52 | PF02991 | 0.624 |
LIG_LIR_Gen_1 | 477 | 484 | PF02991 | 0.634 |
LIG_LIR_Nem_3 | 442 | 448 | PF02991 | 0.447 |
LIG_LIR_Nem_3 | 477 | 483 | PF02991 | 0.582 |
LIG_PTAP_UEV_1 | 132 | 137 | PF05743 | 0.316 |
LIG_PTB_Apo_2 | 68 | 75 | PF02174 | 0.284 |
LIG_SH2_CRK | 145 | 149 | PF00017 | 0.344 |
LIG_SH2_CRK | 49 | 53 | PF00017 | 0.497 |
LIG_SH2_GRB2like | 452 | 455 | PF00017 | 0.468 |
LIG_SH2_SRC | 333 | 336 | PF00017 | 0.375 |
LIG_SH2_STAP1 | 259 | 263 | PF00017 | 0.564 |
LIG_SH2_STAT5 | 145 | 148 | PF00017 | 0.300 |
LIG_SH2_STAT5 | 176 | 179 | PF00017 | 0.492 |
LIG_SH2_STAT5 | 246 | 249 | PF00017 | 0.341 |
LIG_SH2_STAT5 | 342 | 345 | PF00017 | 0.355 |
LIG_SH2_STAT5 | 448 | 451 | PF00017 | 0.450 |
LIG_SH2_STAT5 | 480 | 483 | PF00017 | 0.634 |
LIG_SH3_3 | 130 | 136 | PF00018 | 0.344 |
LIG_SH3_3 | 217 | 223 | PF00018 | 0.586 |
LIG_SH3_3 | 311 | 317 | PF00018 | 0.596 |
LIG_SH3_3 | 518 | 524 | PF00018 | 0.565 |
LIG_SH3_3 | 566 | 572 | PF00018 | 0.598 |
LIG_SUMO_SIM_par_1 | 79 | 86 | PF11976 | 0.591 |
LIG_TRAF2_1 | 120 | 123 | PF00917 | 0.445 |
LIG_TRFH_1 | 176 | 180 | PF08558 | 0.462 |
LIG_TYR_ITIM | 478 | 483 | PF00017 | 0.675 |
LIG_UBA3_1 | 150 | 158 | PF00899 | 0.344 |
LIG_UBA3_1 | 290 | 299 | PF00899 | 0.506 |
MOD_CDK_SPK_2 | 568 | 573 | PF00069 | 0.569 |
MOD_CK1_1 | 241 | 247 | PF00069 | 0.381 |
MOD_CK1_1 | 41 | 47 | PF00069 | 0.515 |
MOD_CK1_1 | 453 | 459 | PF00069 | 0.690 |
MOD_CK1_1 | 463 | 469 | PF00069 | 0.549 |
MOD_CK1_1 | 472 | 478 | PF00069 | 0.533 |
MOD_CK1_1 | 485 | 491 | PF00069 | 0.569 |
MOD_CK2_1 | 117 | 123 | PF00069 | 0.389 |
MOD_CK2_1 | 279 | 285 | PF00069 | 0.515 |
MOD_CK2_1 | 318 | 324 | PF00069 | 0.774 |
MOD_CK2_1 | 516 | 522 | PF00069 | 0.706 |
MOD_GlcNHglycan | 224 | 227 | PF01048 | 0.617 |
MOD_GlcNHglycan | 30 | 33 | PF01048 | 0.719 |
MOD_GlcNHglycan | 455 | 458 | PF01048 | 0.615 |
MOD_GlcNHglycan | 487 | 490 | PF01048 | 0.616 |
MOD_GlcNHglycan | 518 | 521 | PF01048 | 0.684 |
MOD_GlcNHglycan | 546 | 549 | PF01048 | 0.598 |
MOD_GSK3_1 | 273 | 280 | PF00069 | 0.592 |
MOD_GSK3_1 | 372 | 379 | PF00069 | 0.444 |
MOD_GSK3_1 | 38 | 45 | PF00069 | 0.680 |
MOD_GSK3_1 | 437 | 444 | PF00069 | 0.499 |
MOD_GSK3_1 | 522 | 529 | PF00069 | 0.692 |
MOD_GSK3_1 | 79 | 86 | PF00069 | 0.534 |
MOD_N-GLC_1 | 453 | 458 | PF02516 | 0.485 |
MOD_N-GLC_2 | 205 | 207 | PF02516 | 0.393 |
MOD_NEK2_1 | 102 | 107 | PF00069 | 0.493 |
MOD_NEK2_1 | 28 | 33 | PF00069 | 0.454 |
MOD_NEK2_1 | 450 | 455 | PF00069 | 0.504 |
MOD_NEK2_1 | 516 | 521 | PF00069 | 0.697 |
MOD_NEK2_1 | 81 | 86 | PF00069 | 0.569 |
MOD_PIKK_1 | 273 | 279 | PF00454 | 0.575 |
MOD_PIKK_1 | 83 | 89 | PF00454 | 0.578 |
MOD_PKA_2 | 136 | 142 | PF00069 | 0.344 |
MOD_PKA_2 | 203 | 209 | PF00069 | 0.470 |
MOD_PKA_2 | 38 | 44 | PF00069 | 0.498 |
MOD_PKA_2 | 450 | 456 | PF00069 | 0.633 |
MOD_PKA_2 | 504 | 510 | PF00069 | 0.568 |
MOD_Plk_1 | 441 | 447 | PF00069 | 0.481 |
MOD_Plk_1 | 469 | 475 | PF00069 | 0.619 |
MOD_Plk_2-3 | 372 | 378 | PF00069 | 0.500 |
MOD_Plk_4 | 102 | 108 | PF00069 | 0.471 |
MOD_Plk_4 | 111 | 117 | PF00069 | 0.442 |
MOD_Plk_4 | 304 | 310 | PF00069 | 0.664 |
MOD_Plk_4 | 511 | 517 | PF00069 | 0.618 |
MOD_ProDKin_1 | 117 | 123 | PF00069 | 0.457 |
MOD_ProDKin_1 | 171 | 177 | PF00069 | 0.533 |
MOD_ProDKin_1 | 247 | 253 | PF00069 | 0.415 |
MOD_ProDKin_1 | 309 | 315 | PF00069 | 0.565 |
MOD_ProDKin_1 | 319 | 325 | PF00069 | 0.626 |
MOD_ProDKin_1 | 460 | 466 | PF00069 | 0.530 |
MOD_SUMO_for_1 | 553 | 556 | PF00179 | 0.705 |
MOD_SUMO_rev_2 | 296 | 304 | PF00179 | 0.580 |
TRG_DiLeu_BaEn_2 | 284 | 290 | PF01217 | 0.502 |
TRG_ENDOCYTIC_2 | 342 | 345 | PF00928 | 0.410 |
TRG_ENDOCYTIC_2 | 386 | 389 | PF00928 | 0.404 |
TRG_ENDOCYTIC_2 | 480 | 483 | PF00928 | 0.643 |
TRG_ER_diArg_1 | 188 | 190 | PF00400 | 0.511 |
TRG_ER_diArg_1 | 209 | 211 | PF00400 | 0.436 |
TRG_ER_diArg_1 | 383 | 385 | PF00400 | 0.529 |
TRG_ER_diArg_1 | 431 | 434 | PF00400 | 0.532 |
TRG_ER_diArg_1 | 49 | 51 | PF00400 | 0.543 |
TRG_ER_diArg_1 | 63 | 65 | PF00400 | 0.283 |
TRG_ER_diArg_1 | 94 | 96 | PF00400 | 0.487 |
TRG_NLS_Bipartite_1 | 189 | 205 | PF00514 | 0.387 |
TRG_Pf-PMV_PEXEL_1 | 270 | 274 | PF00026 | 0.488 |
TRG_Pf-PMV_PEXEL_1 | 288 | 292 | PF00026 | 0.231 |
TRG_Pf-PMV_PEXEL_1 | 94 | 98 | PF00026 | 0.447 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HWK4 | Leptomonas seymouri | 69% | 98% |
A0A0S4IP20 | Bodo saltans | 28% | 73% |
A0A1X0NGG7 | Trypanosomatidae | 40% | 100% |
A0A3S7WQF9 | Leishmania donovani | 100% | 100% |
A0A422NFU0 | Trypanosoma rangeli | 39% | 100% |
A4HC42 | Leishmania braziliensis | 84% | 99% |
C9ZPG2 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 36% | 100% |
E9AG88 | Leishmania infantum | 100% | 100% |
E9AMJ2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 95% | 100% |
O94271 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 21% | 85% |
Q32NQ8 | Xenopus laevis | 23% | 76% |
Q4QI41 | Leishmania major | 97% | 100% |
V5DAD1 | Trypanosoma cruzi | 41% | 100% |